| Sampling methods in clinical research; an educational review M Elfil, A Negida Emergency 5 (1), 2017 | 1001 | 2017 |
| Parkinson’s disease and pesticides: A meta-analysis of disease connection and genetic alterations H Ahmed, AI Abushouk, M Gabr, A Negida, MM Abdel-Daim Biomedicine & Pharmacotherapy 90, 638-649, 2017 | 126 | 2017 |
| Neuroprotective mechanisms of plant extracts against MPTP induced neurotoxicity: Future applications in Parkinson’s disease AI Abushouk, A Negida, H Ahmed, MM Abdel-Daim Biomedicine & Pharmacotherapy 85, 635-645, 2017 | 115 | 2017 |
| Coenzyme Q10 for patients with Parkinson's disease: a systematic review and meta-analysis A Negida, A Menshawy, G El Ashal, Y Elfouly, Y Hani, Y Hegazy, S Fouda, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2016 | 80 | 2016 |
| Sample size calculation guide-part 4: how to calculate the sample size for a diagnostic test accuracy study based on sensitivity, specificity, and the area under the roc curve A Negida, NK Fahim, Y Negida Frontiers in Emergency Medicine 3 (3), e33-e33, 2019 | 79 | 2019 |
| A literature review of traumatic brain injury biomarkers HS Ghaith, AA Nawar, MD Gabra, ME Abdelrahman, MH Nafady, ... Molecular neurobiology 59 (7), 4141-4158, 2022 | 72 | 2022 |
| Meta-analysis of the safety and efficacy of droxidopa for neurogenic orthostatic hypotension A Elgebaly, B Abdelazeim, O Mattar, M Gadelkarim, R Salah, A Negida Clinical Autonomic Research 26, 171-180, 2016 | 56 | 2016 |
| Molecular mechanisms of astaxanthin as a potential neurotherapeutic agent EI Bahbah, S Ghozy, MS Attia, A Negida, TB Emran, S Mitra, ... Marine drugs 19 (4), 201, 2021 | 51 | 2021 |
| C-Abl inhibition; a novel therapeutic target for Parkinson's disease AI Abushouk, A Negida, RA Elshenawy, H Zein, AM Hammad, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2018 | 44 | 2018 |
| Bee venom for the treatment of Parkinson’s disease: how far is it possible? K Awad, AI Abushouk, AH AbdelKarim, M Mohammed, A Negida, ... Biomedicine & Pharmacotherapy 91, 295-302, 2017 | 41 | 2017 |
| Neuropsychological performance changes following subthalamic versus pallidal deep brain stimulation in Parkinson’s disease: a systematic review and metaanalysis A Elgebaly, M Elfil, A Attia, M Magdy, A Negida CNS spectrums 23 (1), 10-23, 2018 | 30 | 2018 |
| Subthalamic and pallidal deep brain stimulation for Parkinson’s disease A Negida, M Elminawy, G El Ashal, A Essam, A Eysa, MAE Aziz Cureus 10 (2), 2018 | 28 | 2018 |
| Sample size calculation guide-part 3: how to calculate the sample size for an independent case-control study NK Fahim, A Negida, AK Fahim Frontiers in Emergency Medicine 3 (2), e20-e20, 2019 | 27 | 2019 |
| Evidence for association between hepatitis C virus and Parkinson’s disease AI Abushouk, MWA El-Husseny, M Magdy, A Ismail, A Attia, H Ahmed, ... Neurological Sciences 38 (11), 1913-1920, 2017 | 27 | 2017 |
| Sample size calculation guide-part 1: how to calculate the sample size based on the prevalence rate NK Fahim, A Negida Advanced Journal of Emergency Medicine 2 (4), 2018 | 26 | 2018 |
| Caffeine; the forgotten potential for Parkinson's disease A Negida, M Elfil, A Attia, E Farahat, M Gabr, A Essam, D Attia, H Ahmed CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2017 | 26 | 2017 |
| Sample size calculation guide-part 7: how to calculate the sample size based on a correlation A Negida Frontiers in Emergency Medicine 4 (2), e34-e34, 2020 | 23 | 2020 |
| Safety and efficacy of levetiracetam for the management of levodopa-induced dyskinesia in patients with Parkinson’s disease: a systematic review MA Ebada, S Alkanj, M Ebada, AH Abdelkarim, A Diab, MAE Aziz, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2019 | 18 | 2019 |
| Sample size calculation guide-part 2: how to calculate the sample size for an independent cohort study NK Fahim, A Negida Frontiers in Emergency Medicine 3 (1), e12-e12, 2019 | 17 | 2019 |
| Mavoglurant (AFQ056) for the treatment of levodopa-induced dyskinesia in patients with Parkinson’s disease: a meta-analysis A Negida, HS Ghaith, SY Fala, H Ahmed, EI Bahbah, MA Ebada, ... Neurological Sciences 42 (8), 3135-3143, 2021 | 15 | 2021 |
Matthew J. BarrettAssociate Professor of Neurology, Virginia Commonwealth University在 vcuhealth.org 的电子邮件经过验证
